Clinical trial
Trial II of Lung Protection With Azithromycin in the Preterm Infant
NCT00319956 · Hubert Ballard, Other · Completed
Key facts
| NCT number | NCT00319956 |
|---|---|
| Title | Trial II of Lung Protection With Azithromycin in the Preterm Infant |
| Official title | Trial II of Lung Protection With Azithromycin in the Preterm Infant |
| Lead sponsor | Hubert Ballard, Other |
| Collaborators | American Lung Association |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Bronchopulmonary Dysplasia |
| Intervention type | Drug |
| Interventions | Azithromycin, Placebo |
| Enrollment | 220 |
| Start date | Sep 1, 2004 |
| Primary completion | Jun 1, 2012 |
| Completion | Jun 1, 2012 |
| First posted | Apr 27, 2006 |
| Last update posted | Jun 27, 2018 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: